Form 4 for HCA HCA Healthcare
Accepted 2024-11-13 00:00:00 ET · period of report 2024-11-11 · accession 0000950170-24-126550 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-13 | 2024-11-11 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | F - Tax | $357.99 | -3,236 | 10.9K | -23% | -$1.16M |
| D | 2024-11-13 | 2024-11-11 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | M - OptEx | $173.12 | +4,710 | 14.2K | +50% | +$815.4K |
| D | 2024-11-13 | 2024-11-11 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | M - OptEx | $0.00 | -4,710 | 1,570 | -75% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-11 | F | D | 3,236 | $357.99 | 10,928 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-11 | M | A | 4,710 | $173.12 | 14,164 | D | — | — | |
| 3 | Derivative | Stock Appreciation Right | 2024-11-11 | M | D | 4,710 | $0.00 | 1,570 | D | $173.12 · — to 2031-02-03 | 4,710 Common Stock | (F1) The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. |